Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001235802-25-000007
Filing Date
2025-01-17
Accepted
2025-01-17 16:29:24
Documents
1
Period of Report
2024-04-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 4888
  Complete submission text file 0001235802-25-000007.txt   6505
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Issuer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address
Schallenberger Mark A. (Reporting) CIK: 0001960742 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34951 | Film No.: 25539036